» Articles » PMID: 10491855

Knowledge-based Expert Systems for Toxicity and Metabolism Prediction: DEREK, StAR and METEOR

Overview
Date 1999 Sep 24
PMID 10491855
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

It has long been recognised that the ability to predict the metabolic fate of a chemical substance and the potential toxicity of either the parent compound or its metabolites are important in novel drug design. The popularity of using computer models as an aid in this area has grown considerably in recent years. LHASA Limited has been developing knowledge-based expert systems for toxicity and metabolism prediction in collaboration with industry and regulatory authorities. These systems, DEREK, StAR and METEOR, use rules to describe the relationship between chemical structure and either toxicity in the case of DEREK and StAR, or metabolic fate in the case of METEOR. The rule refinement process for DEREK often involves assessing the predictions for a novel set of compounds and comparing them to their biological assay results as a measure of the system's performance. For example, 266 non-congeneric chemicals from the National Toxicology Program database have been processed through the DEREK mutagenicity knowledge base and the predictions compared to their Salmonella typhimurium mutagenicity data. Initially, 81 of 114 mutagens (71%) and 117 of 152 non-mutagens (77%) were correctly identified. Following further knowledge base development, the number of correctly identified mutagens has increased to 96 (84%). Further work on improving the predictive capabilities of DEREK, StAR and METEOR is in progress.

Citing Articles

Should Transformation Products Change the Way We Manage Chemicals?.

Zahn D, Arp H, Fenner K, Georgi A, Hafner J, Hale S Environ Sci Technol. 2024; 58(18):7710-7718.

PMID: 38656189 PMC: 11080041. DOI: 10.1021/acs.est.4c00125.


In-Silico Drug Toxicity and Interaction Prediction for Plant Complexes Based on Virtual Screening and Text Mining.

Zhang F, Ganesan K, Li Y, Chen J Int J Mol Sci. 2022; 23(17).

PMID: 36077464 PMC: 9456415. DOI: 10.3390/ijms231710056.


Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects.

Gopalswamy M, Kroeger T, Bickel D, Frieg B, Akter S, Schott-Verdugo S Sci Rep. 2022; 12(1):14158.

PMID: 35986043 PMC: 9391460. DOI: 10.1038/s41598-022-17913-6.


A Computational Approach Applied to the Study of Potential Allosteric Inhibitors Protease NS2B/NS3 from Dengue Virus.

Costa R, Rocha J, Pinheiro A, Costa A, Rocha E, Silva R Molecules. 2022; 27(13).

PMID: 35807364 PMC: 9268547. DOI: 10.3390/molecules27134118.


Increasing the Value of Data Within a Large Pharmaceutical Company Through In Silico Models.

Brigo A, Naga D, Muster W Methods Mol Biol. 2022; 2425:637-674.

PMID: 35188649 DOI: 10.1007/978-1-0716-1960-5_24.